- Description
- Table of Contents
- Request Sample
The Global Protein Therapeutics market is expected to reach $302915.63 million by 2026 growing at a CAGR of 8.4% from 2018 to 2026. Protein Therapeutics drugs are a significant class of medicines, which are administered to treat a variety of different diseases such as cancer, infectious diseases, and others. These drugs hold huge potential to improve human health. Some of the factors such as the increasing predominance of chronic diseases and advancement of plasma-derived therapies are fuelling the market growth. However, stringent government regulations and high treatment costs per patient are restraining market growth. Based on the product, the monoclonal antibodies segment has witnessed significant growth owing to the necessity and applicability of these products in the treatment of different chronic disorders. Monoclonal antibodies can be used alone or to carry drugs and radioactive or toxic substances directly to cancer cells. Monoclonal antibodies that are used as drugs assist the natural immune system's function in fighting cancer. These medications may be used in combination with other cancer treatments. The key vendors mentioned are Pfizer, Novo Nordisk, Merck, Johnson & Johnson, Generex Biotechnology, F. Hoffmann-La Roche, Eli Lilly, Baxter International, Amgen and AbbVie. Products Covered: • Monoclonal Antibody • Interferon • Insulin • Human Growth Hormone • Granulocyte-Colony Stimulating Factor (G-CSF) • Fusion Protein • Follicle-Stimulating Hormone • Erythropoietin • Blood Clotting Factor Protein Functions Covered: • Vaccines • Protein Diagnostics • Enzymatic and Regulatory Applications Covered: • Protein Vaccine • Metabolic and Endocrine Disorders • Infectious Diseases • Immunological Disorders • Hormonal Disorders • Haematological Disorders • Genetic Disorders • Cancer • Other Applications Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Protein Therapeutics Market, By Product
5.1 Introduction
5.2 Monoclonal Antibody
5.3 Interferon
5.4 Insulin
5.5 Human Growth Hormone
5.6 Granulocyte-Colony Stimulating Factor (G-CSF)
5.7 Fusion Protein
5.8 Follicle-Stimulating Hormone
5.9 Erythropoietin
5.10 Blood Clotting Factor
6 Global Protein Therapeutics Market, By Protein Function
6.1 Introduction
6.2 Vaccines
6.3 Protein Diagnostics
6.4 Enzymatic and Regulatory
7 Global Protein Therapeutics Market, By Application
7.1 Introduction
7.2 Protein Vaccine
7.3 Metabolic and Endocrine Disorders
7.4 Infectious Diseases
7.5 Immunological Disorders
7.6 Hormonal Disorders
7.7 Hematological Disorders
7.8 Genetic Disorders
7.9 Cancer
7.10 Other Applications
8 Global Protein Therapeutics Market, By Geography
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 South America
8.6 Middle East & Africa
9 Strategic Benchmarking
10 Vendors Landscape
10.1 Pfizer
10.2 Novo Nordisk
10.3 Merck
10.4 Johnson & Johnson
10.5 Generex Biotechnology
10.6 F. Hoffmann-La Roche
10.7 Eli Lilly
10.8 Baxter International
10.9 Amgen
10.10 AbbVie
List of Data Tables
Table 1 Global Protein Therapeutics Market Outlook, By Region (2017-2026) ($MN)
Table 2 Global Protein Therapeutics Market Outlook, By Product (2017-2026) ($MN)
Table 3 Global Protein Therapeutics Market Outlook, By Monoclonal Antibody (2017-2026) ($MN)
Table 4 Global Protein Therapeutics Market Outlook, By Interferon (2017-2026) ($MN)
Table 5 Global Protein Therapeutics Market Outlook, By Insulin (2017-2026) ($MN)
Table 6 Global Protein Therapeutics Market Outlook, By Human Growth Hormone (2017-2026) ($MN)
Table 7 Global Protein Therapeutics Market Outlook, By Granulocyte-Colony Stimulating Factor (G-CSF) (2017-2026) ($MN)
Table 8 Global Protein Therapeutics Market Outlook, By Fusion Protein (2017-2026) ($MN)
Table 9 Global Protein Therapeutics Market Outlook, By Follicle-Stimulating Hormone (2017-2026) ($MN)
Table 10 Global Protein Therapeutics Market Outlook, By Erythropoietin (2017-2026) ($MN)
Table 11 Global Protein Therapeutics Market Outlook, By Blood Clotting Factor (2017-2026) ($MN)
Table 12 Global Protein Therapeutics Market Outlook, By Protein Function (2017-2026) ($MN)
Table 13 Global Protein Therapeutics Market Outlook, By Vaccines (2017-2026) ($MN)
Table 14 Global Protein Therapeutics Market Outlook, By Protein Diagnostics (2017-2026) ($MN)
Table 15 Global Protein Therapeutics Market Outlook, By Enzymatic and Regulatory (2017-2026) ($MN)
Table 16 Global Protein Therapeutics Market Outlook, By Application (2017-2026) ($MN)
Table 17 Global Protein Therapeutics Market Outlook, By Protein Vaccine (2017-2026) ($MN)
Table 18 Global Protein Therapeutics Market Outlook, By Metabolic and Endocrine Disorders (2017-2026) ($MN)
Table 19 Global Protein Therapeutics Market Outlook, By Infectious Diseases (2017-2026) ($MN)
Table 20 Global Protein Therapeutics Market Outlook, By Immunological Disorders (2017-2026) ($MN)
Table 21 Global Protein Therapeutics Market Outlook, By Hormonal Disorders (2017-2026) ($MN)
Table 22 Global Protein Therapeutics Market Outlook, By Hematological Disorders (2017-2026) ($MN)
Table 23 Global Protein Therapeutics Market Outlook, By Genetic Disorders (2017-2026) ($MN)
Table 24 Global Protein Therapeutics Market Outlook, By Cancer (2017-2026) ($MN)
Table 25 Global Protein Therapeutics Market Outlook, By Other Applications (2017-2026) ($MN)
Table 26 North America Protein Therapeutics Market Outlook, By Product (2017-2026) ($MN)
Table 27 North America Protein Therapeutics Market Outlook, By Protein Function (2017-2026) ($MN)
Table 28 North America Protein Therapeutics Market Outlook, By Application (2017-2026) ($MN)
Table 29 Europe Protein Therapeutics Market Outlook, By Product (2017-2026) ($MN)
Table 30 Europe Protein Therapeutics Market Outlook, By Protein Function (2017-2026) ($MN)
Table 31 Europe Protein Therapeutics Market Outlook, By Application (2017-2026) ($MN)
Table 32 Asia Pacific Protein Therapeutics Market Outlook, By Product (2017-2026) ($MN)
Table 33 Asia Pacific Protein Therapeutics Market Outlook, By Protein Function (2017-2026) ($MN)
Table 34 Asia Pacific Protein Therapeutics Market Outlook, By Application (2017-2026) ($MN)
Table 35 South America Protein Therapeutics Market Outlook, By Product (2017-2026) ($MN)
Table 36 South America Protein Therapeutics Market Outlook, By Protein Function (2017-2026) ($MN)
Table 37 South America Protein Therapeutics Market Outlook, By Application (2017-2026) ($MN)
Table 38 Middle East & Africa Protein Therapeutics Market Outlook, By Product (2017-2026) ($MN)
Table 39 Middle East & Africa Protein Therapeutics Market Outlook, By Protein Function (2017-2026) ($MN)
Table 40 Middle East & Africa Protein Therapeutics Market Outlook, By Application (2017-2026) ($MN)